Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "V3 receptors" is incorrect and does not refer to a recognized molecular target or receptor. Instead, the V3 loop (or third variable region) is a specific segment within the envelope glycoprotein gp120 of Human Immunodeficiency Virus type 1 (HIV-1). The V3 loop plays a critical role in determining which chemokine co-receptor—either CCR5 or CXCR4—the virus will use to enter host cells[2][5][1]. This specificity influences viral tropism and disease progression. The V3 loop itself is not a receptor but rather a structural motif on the virus that interacts with host cell receptors; thus, it should not be listed as a therapeutic target or classified as a receptor[2][5]. Drugs such as Maraviroc act by targeting CCR5, one of the actual cellular co-receptors engaged by the V3 loop during HIV entry[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V3 receptors.